Back to All Events

Antimicrobial Drug Advisory Committee (AMDAC)

  • IQVIA Solutions Denmark A/S Denmark (map)

The AMDAC committee will discuss new drug application (NDA-216974) for sulbactam-durlobactam injection, submitted by Entasis Therapeutics for the proposed treatment of hospital‐acquired bacterial pneumonia (HABP) and ventilator‐associated bacterial pneumonia (VABP) caused by susceptible strains of Acinetobacter baumannii‐calcoaceticus complex (ABC) in adults.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-information-april-17-2023-meeting-antimicrobial-drugs-advisory-committee-meeting
Earlier Event: April 14
The Psychopharmacologic Drugs Advisory Committee (PDAC)/Peripheral and Central Nervous System Drugs Advisory Committee (PDAC)
Later Event: April 26
Blood Products Advisory Committee